中国边境口岸进口药材市场调查及现状分析  

Investigation and analysis of imported medicinal materials at Chinese border ports

作　　者：马晓晶[1] 彭华胜[1,2] 詹志来 王凌 黄雪彦[3] 李晓瑾[4] 马小军 黄海波[6] 李旻辉[7] 赵容 黄璐琦[1] MA Xiao-jing;PENG Hua-sheng;ZHAN Zhi-lai;WANG Ling;HUANG Xue-yan;LI Xiao-jin;MA Xiao-jun;HUANG Hai-bo;LI Min-hui;ZHAO Rong;HUANG Lu-qi(State Key Laboratory Breeding Base of Dao-di Herbs,National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Bejing 100700,China;Research Unit of Dao-di Herbs(2019RU57),Chinese Academy of Medical Sciences,Bejing 100700,China;Guangxi TCM Resources General Survey and Data Collection Key Laboratory,Guangxi Botanical Garden of Medicinal Plants,Nanning 530023,China;Xinjiang Institute of Chinese Materia Medica and Eithnical Materia,Urumqi 830002,China;Yunnan Key Laboratory of Southern Medicine Utilization,Yunnan Branch of Institule of Medicinal Plant Development,Chinese Academy of Medical Sciences,Jinghong 666100,China;School of Chinese Herbal Medicine,Guangzhou University of Chinese Medicine,Guangzhou 510006,China;Inner Mongolia Autonomous Region Academy of Chinese Medicine,Hohhot 010110,China;College of Pharmacy,Liaoning University of Traditional Chinese Medicine,Dalian 116600,China)

机构地区：[1]中国中医科学院中药资源中心道地药材国家重点实验室培育基地,北京100700 [2]中国医学科学院道地药材研究创新单元(2019RU57),北京100700 [3]广西壮族自治区药用植物园广西中药资源普查与研究重点实验室,广西南宁530023 [4]新疆维吾尔自治区中药民族药研究所,新疆乌鲁木齐830002 [5]中国医学科学院,药用植物研究所,云南分所,云南省南药可持续利用研究重点实验室,云南景洪666100 [6]广州中医药大学中药学院,广东广州510006 [7]内蒙古自治区中医药研究所,内蒙古呼和浩特010110 [8]辽宁中医药大学药学院,辽宁大连116600

出　　处：《中国中药杂志》2022年第21期5817-5823,共7页China Journal of Chinese Materia Medica

基　　金：中国医学科学院医学与健康科技创新工程项目(2019-I2M-5-065);中央本级重大增减支项目(2060302)。

摘　　要：进口药材是我国中药资源的重要组成部分,我国常用的近600种中药材中,约有10%需要进口,进口药材的输入,极大地丰富了我国的药用资源,推动了中医药学的发展。近年来,随着改革开放的不断深入和“一带一路”倡议的实施,我国边境贸易得到长足发展,使边境口岸输入的进口药材发生了新的变化。但是长期以来,对于边境口岸进口药材的整体情况尚缺乏系统的调查,中国中医科学院中药资源中心在第四次全国中药资源普查的基础上,联合全国多家单位,首次对我国6个省(自治区)近40个边境口岸、中药材市场、边贸集市等开展专项走访调查,收集并记录了进口药材品种、来源、流通、交易特点等信息,并组织有关专家对采集的237种进口药材样品进行基原鉴定。该文在前期实地调查的基础上,结合进口药材基原鉴定结果,论述了边境口岸特点、进口药材输入国特点、进口药材情况及存在的问题等,并提出建议,以期为摸清进口药材市场现状、厘清进口药材基原,促进进口药材的科学研究和监管提供参考。Imported medicinal materials are an important part of Chinese medicinal resources. To be specific, about 10% of the around 600 commonly used Chinese medicinal materials are from abroad, and the introduction of foreign medicinal materials has promoted the development of Chinese medicine. Amid the advancement of reform and opening up and the “Belt and Road” Initiative, major headway has been made in the cross-border trade in China, bringing opportunities for the import of medicinal materials from border ports. However, for a long time, there is a lack of systematic investigation on the types of exotic medicinal materials at border ports. In the fourth national census of traditional Chinese medicine resources, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, together with several organizations, investigated the nearly 40 border ports, Chinese medicinal material markets, and border trade markets in 6 provinces/autonomous regions in China for the first time and recorded the types, sources, circulation, and the transaction characteristics of imported medicinal materials. Moreover, they invited experts to identify the origins of the collected 237 medicinal materials. In addition, the status quo and the problems of the medicinal materials were summarized. This study is expected to lay a basis for clarifying the market and origins of imported medicinal materials as well as the scientific research on and supervision of them.

关 键 词：进口药材 药材基原 市场调查 

分 类 号：F323.7[经济管理—产业经济] F752.61